Evidence map›Paper›PMID 42293267›Full record

ArticleJournal of advanced pharmaceutical technology & research

Seeing through the patient's Eyes: Exploring quality of life in glaucoma patients.

Nour Aymn Ahmad, Sathvik Belagodu Sridhar, Javedh Shareef, Ajay Kamath

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of advanced pharmaceutical technology & research. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nour Aymn AhmadDepartment of Clinical Pharmacy and Pharmacology, RAK College of Pharmacy, RAK Medical and Health Sciences University, Ras Al Khaimah, UAE.
Sathvik Belagodu SridharDepartment of Pharmacy Practice, College of Pharmacy, Dubai Medical University, UAE.
Javedh ShareefDepartment of Clinical Pharmacy and Pharmacology, RAK College of Pharmacy, RAK Medical and Health Sciences University, Ras Al Khaimah, UAE.
Ajay KamathDepartment of Ophthalmology, Clinical Scienecs Division, NOSM University, Thunder Bay, Ontario, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glaucoma remains the predominant cause of irreversible blindness and has a profound multidimensional impact on every patient's life. Assessment of vision-related quality of life (VR-QOL) is paramount for comprehensive glaucoma management. To evaluate VR-QOL among patients with glaucoma at a secondary care hospital in the United Arab Emirates. This cross-sectional study was undertaken in the ophthalmology outpatient clinic between July 2021 and February 2022. Individuals were recruited using stratified random sampling, and controls were frequency-matched by age and gender. VR-QOL was measured using the validated NEI-VFQ-25 questionnaire. Descriptive statistics, Mann-Whitney

Indexed as

NEI-VFQ-25patient-reported outcomesvision disordersvision-related quality of life

Identifiers

PMID42293267
PMCPMC13262906

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.